journal cover

Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB

Cytokine

Dec 16, 2004

Christian VestergaardLars Iversen

Download from

Publisher
PubMed

Abstract

CTACK/CCL27 is pivotal in mediating the migration of lymphocytes into the skin, through the binding to the chemokine receptor CCR10. CCL27 is continuously expressed by keratinocytes, but highly upregulated in inflammatory skin diseases such as atopic dermatitis and psoriasis. CCL27 can ...read more

Mentioned in this Paper

Pathologic Cytolysis
Beta-Chemokines
Biochemical Pathway
Psoriasis
Exertion
Deoxyribonuclease I
Tissue Membrane
Tumor Necrosis Factor-alpha
Dermatitis, Atopic
Gentamicins
15
1
Paper Details
References
  • References25
  • Citations40
123
  • References25
  • Citations40
1234

Feeds With Similar Papers

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Chemokines & Chemokine Receptors

Chemokines are a subset of cytokines which induce chemotaxis in cells expressing chemokine receptors. Chemokines can be broadly categorized into two functional subgroups, homeostatic (basal expression in lymphoid tissues for surveillance purposes) or inflammatory (released during injury to recruit immune effector cells). Chemokine receptors are G-protein coupled receptors which, upon chemokine binding, induce calcium influx into the cell. Find the latest research on chemokines and chemokine receptors here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

The Journal of Allergy and Clinical Immunology

Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes(opens in new tab)

The Journal of Allergy and Clinical ImmunologyDecember 4, 2004
Naoko KandaShinichi Watanabe
The Journal of Allergy and Clinical Immunology

IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes(opens in new tab)

The Journal of Allergy and Clinical ImmunologyNovember 9, 2005
Naoko KandaShinichi Watanabe
© 2020 Meta ULC. All rights reserved

Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB

Cytokine

Dec 16, 2004

Christian VestergaardLars Iversen

PMID: 15598438

DOI: 10.1016/j.cyto.2004.09.008

Abstract

CTACK/CCL27 is pivotal in mediating the migration of lymphocytes into the skin, through the binding to the chemokine receptor CCR10. CCL27 is continuously expressed by keratinocytes, but highly upregulated in inflammatory skin diseases such as atopic dermatitis and psoriasis. CCL27 can ...read more

Mentioned in this Paper

Pathologic Cytolysis
Beta-Chemokines
Biochemical Pathway
Psoriasis
Exertion
Deoxyribonuclease I
Tissue Membrane
Tumor Necrosis Factor-alpha
Dermatitis, Atopic
Gentamicins
15
1

Feeds With Similar Papers

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

The Journal of Allergy and Clinical Immunology

Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes(opens in new tab)

The Journal of Allergy and Clinical ImmunologyDecember 4, 2004
Naoko KandaShinichi Watanabe
The Journal of Allergy and Clinical Immunology

IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes(opens in new tab)

The Journal of Allergy and Clinical ImmunologyNovember 9, 2005
Naoko KandaShinichi Watanabe
Paper Details
References
  • References25
  • Citations40
123
  • References25
  • Citations40
1234

Download from

Publisher
PubMed
/papers/tumor-necrosis-factor-alpha-induced-ctackccl27/15598438